Streetbeat News

Stock Prices

IMGN

Piper Sandler analyst Joseph Catanzaro has downgraded Immunogen (NASDAQ:IMGN) from Overweight to Neutral, while also raising the price target for the company's stock from $24 to $31.

Portfolio Pulse from Benzinga Newsdesk

December 04, 2023 | 1:06 pm

ANSS

Ansys, Inc. has announced that Nicole Anasenes, the company's CFO and Senior Vice President of Finance, will leave the company in the second quarter of 2024. Ansys is currently searching for a new CFO, and Anasenes will assist in the transition process.

Portfolio Pulse from Benzinga Newsdesk

December 04, 2023 | 1:06 pm

FDMT

4D Molecular Therapeutics will present interim data from the Phase 2 PRISM trial at the Angiogenesis, Exudation, and Degeneration 2024 Conference. The data pertains to the 24-week randomized dose expansion stage of the trial.

Portfolio Pulse from Benzinga Newsdesk

December 04, 2023 | 1:05 pm

SLNA

Selina Hospitality PLC (NASDAQ: SLNA) announced plans for fundraising and liability management, including a potential $68 million in strategic investments led by Osprey Investments Limited and others. The company aims to restructure its $147.5 million 6.00% convertible senior notes due 2026, with agreements in principle for a $28 million equity financing and an optional $40 million equity financing. The restructuring includes converting some debt to equity, extending maturity dates, and securing the Selina brand as collateral. The transactions are subject to definitive agreements and shareholder approval, with the goal of strengthening the balance sheet and achieving profitability.

Portfolio Pulse from Benzinga Newsdesk

December 04, 2023 | 1:04 pm

MIRA

MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) has announced promising results from AI simulations for MIRA1a, a potential treatment for anxiety, appetite, and cognition issues. The simulations, conducted with InSilicoTrials, suggest MIRA1a's advantages over THC, including fewer side effects. MIRA1a targets specific brain receptors and may offer superior anti-anxiety effects, appetite suppression, and cognitive enhancement. The company is working towards an IND Application with the FDA, positioning MIRA1a as a significant development in neuropharmacology.

Portfolio Pulse from Benzinga Newsdesk

December 04, 2023 | 1:03 pm

LAB

SLGC

Standard BioTools Inc. (LAB) and SomaLogic, Inc. (SLGC) have announced the date for their Special Meetings of Stockholders to vote on their proposed all-stock merger. The meetings are scheduled for January 4, 2024, with stockholders of record as of November 29, 2023, eligible to vote. The merger is expected to close in the first quarter of 2024, pending stockholder approval and other customary closing conditions. Proxy solicitors have been appointed to assist stockholders with voting.

Portfolio Pulse from Benzinga Newsdesk

December 04, 2023 | 1:01 pm

DECK

Over the past 3 months, 8 Wall Street analysts have provided ratings for Deckers Outdoor (NYSE:DECK), with 3 bullish, 4 somewhat bullish, and 1 indifferent. No bearish ratings were reported. The 12-month price target for DECK averages $676.25, ranging from $600.00 to $750.00. This target has increased by 2.89% over the past month. Analyst ratings are opinions on stock performance and are updated quarterly, reflecting research and financial analysis.

Portfolio Pulse from Benzinga Insights

December 04, 2023 | 1:00 pm

ALK

HA

Hawaiian Airlines (NASDAQ:HA) shares surged over 180% in pre-market trading following the announcement that Alaska Air Group, Inc. (NYSE:ALK) plans to acquire the company for $1.9 billion. The merger is expected to expand domestic and international options for customers. Other stocks showed significant movement in pre-market trading, with notable gainers including Hut 8 Mining Corp (NASDAQ:HUT) and Bit Brother Limited (NASDAQ:BETS), and losers such as NLS Pharmaceutics AG (NASDAQ:NLSP) and Panbela Therapeutics, Inc. (NASDAQ:PBLA).

Portfolio Pulse from Lisa Levin

December 04, 2023 | 1:00 pm

CNM

Core & Main, Inc. (NYSE:CNM) is expected to release its Q3 financial results on Dec. 5, 2023, with analysts predicting an EPS of 68 cents, up from 67 cents a year ago, and revenue of $1.83 billion. The company completed the acquisition of assets from Enviroscape ECM, Ltd. CNM's stock closed up 2.8% at $36.00. Analysts from RBC Capital, Wolfe Research, Citigroup, Barclays, and Goldman Sachs have provided ratings and price targets for CNM, with various adjustments and accuracy rates.

Portfolio Pulse from Lisa Levin

December 04, 2023 | 1:00 pm

FSR

Fisker (NYSE:FSR) has been rated by analysts in the last quarter with 1 bullish, 1 indifferent, and 2 somewhat bearish ratings. The average 12-month price target among 4 analysts is $4.25, with a high of $8.00 and a low of $2.00, representing a 15.0% decrease from the previous target of $5.00. Analyst ratings are based on future earnings and revenue predictions and are updated quarterly or after major company events.

Portfolio Pulse from Benzinga Insights

December 04, 2023 | 1:00 pm